Theliatinib
Theliatinib, a potent and highly selective EGFR inhibitor, with anti-tumor activity. Ki of 0.05 nM for wild type EGFR, and IC50s of 3 and 22 nM for EGFR and EGFR T790M/L858R mutant, respectively.

Catalog Number | T7322 |
Research Area | Tyrosine Kinase/Adaptors|||Angiogenesis|||JAK/STAT signaling |
Molecular Formula | C25H26N6O2 |
CAS# | 1353644-70-8 |
Purity | 98.00% |
SMILES | [H][C@]12CCN(C)[C@@]1([H])CN(C2)C(=O)Nc1cc2c(Nc3cccc(c3)C#C)ncnc2cc1OC |
Size | 1 mg |
Supplier Page | https://www.targetmol.com/compound/Theliatinib |
Additional Information | https://www.targetmol.com/datasheet/T7322 |